Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01899326|
Recruitment Status : Unknown
Verified January 2016 by Murali Janakiram, Albert Einstein College of Medicine, Inc..
Recruitment status was: Active, not recruiting
First Posted : July 15, 2013
Last Update Posted : January 12, 2016
Albert Einstein College of Medicine, Inc.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Murali Janakiram, Albert Einstein College of Medicine, Inc.
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Actual Primary Completion Date :||March 2015|
|Study Completion Date :||No date given|